KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $169.6 million.

  • Charles River Laboratories International's Accounts Payables rose 2475.09% to $169.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.6 million, marking a year-over-year increase of 2475.09%. This contributed to the annual value of $140.3 million for FY2024, which is 1692.94% down from last year.
  • Per Charles River Laboratories International's latest filing, its Accounts Payables stood at $169.6 million for Q3 2025, which was up 2475.09% from $145.8 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Accounts Payables high stood at $226.0 million for Q1 2022, and its period low was $110.9 million during Q2 2021.
  • In the last 5 years, Charles River Laboratories International's Accounts Payables had a median value of $140.3 million in 2024 and averaged $155.7 million.
  • In the last 5 years, Charles River Laboratories International's Accounts Payables skyrocketed by 9056.04% in 2022 and then plummeted by 4689.55% in 2023.
  • Over the past 5 years, Charles River Laboratories International's Accounts Payables (Quarter) stood at $198.1 million in 2021, then grew by 3.93% to $205.9 million in 2022, then fell by 17.96% to $168.9 million in 2023, then fell by 16.93% to $140.3 million in 2024, then increased by 20.86% to $169.6 million in 2025.
  • Its last three reported values are $169.6 million in Q3 2025, $145.8 million for Q2 2025, and $149.3 million during Q1 2025.